U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Testing and Labeling Medical Devices for Safety in the Magnetic Resonance (MR) Environment
  1. Regulatory Information

GUIDANCE DOCUMENT

Testing and Labeling Medical Devices for Safety in the Magnetic Resonance (MR) Environment Guidance for Industry and Food and Drug Administration Staff August 2019

Draft

Not for implementation. Contains non-binding recommendations.

This guidance is being distributed for comment purposes only.

Submit Comments by

Although you can comment on any guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that the FDA considers your comment on a draft guidance before it begins work on the final version of the guidance, submit either online or written comments on the draft guidance before the close date.

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2019-D-2837


Docket Number:
FDA-2019-D-2837
Issued by:
Guidance Issuing Office
Center for Devices and Radiological Health

This draft guidance document provides Food and Drug Administration’s recommendations on testing to assess the safety and compatibility of medical devices in the Magnetic Resonance (MR) Environment and the recommended format for Magnetic Resonance Imaging (MRI) Safety Information in medical device labeling.